•  
  •  
  •  
  •  

2025-10-02 09:38:30

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue

Keywords Selected:  SupriyaLifescience

Research

  • IPO Review - Supriya Lifescience Ltd - ICICI Direct
  • Supriya Lifescience - IPO - Strong R&D Focused API Player - Reliance Research

Stock Report

  • Supriya Lifescience Ltd Q3 FY2025 PAT up at Rs. 46.78 crores
  • Supriya Lifescience Ltd inaugurates State-of-the-Art Module E Production Block at Lote Parshuram, Maharashtra
  • Supriya Lifescience expands global footprint with Esketamine Hydrochloride approval & Atorvastatin patent filing
  • Supriya Lifesciences Ltd received GMP certification from ANVISA Brazil
  • Supriya Lifescience Ltd Q1 FY2024 net profit at Rs. 2.85 crore
  • Supriya Lifescience Ltd and Plasma Nutrition, Inc Announce Groundbreaking Collaboration in Protein Technology
  • Supriya Lifescience Ltd recommends final dividend of Rs. 0.60
  • Supriya Lifescience Ltd Q4FY2023 PAT at Rs. 38.22 crores
  • EDQM grants EU-GMP for Lote API facility of Supriya Lifescience Limited
  • Supriya Lifescience Ltd signs Captive Solar Project Agreement
  • Supriya Lifescience Ltd Q2 FY2023 profit falls to Rs. 16.86 crores
  • Supriya Lifescience Limited Announces Mr. Rajeev Kumar Jain as CEO & KMP

Latest Post

  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024